AKAhmad Mohammad Khalil

Ahmad Mohammad Khalil

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ahmad Mohammad Khalil has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Applications of CRISPR-Cas9 Gene Editing Technology in Food Allergy Therapy: A Comprehensive Review

    by Ahmad M. Khalil

    Worldwide, the incidence of allergenicity is rising rapidly, making it an ongoing clinical challenge and public health concern. The current treatment options for allergies include allergen avoidance, medications to improve symptoms, and immunotherapy to desensitize affected individuals to specific allergens. However, these approaches have limitations, and there is an urgent need for novel and more effective therapies. Allergies are a compelling candidate for gene editing (GE) given their prevalence and the inadequacies of existing treatments. Repurposing present allergy medications and emerging novel therapies may be possible with the aid of genomics-guided determination of prospective therapeutic targets for the illness. The emergence of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-GE technology, which uses RNA to guide DNA targeting, has allowed the generation of customized organisms for specific traits. The novel genome-editing tools have shown promising potential to transform allergy research and treatment, offering new hope for patients with severe allergies. By allowing accurate alterations of the genome, GE can be used to delete, correct specific allergen gene (s) that make a person susceptible to allergies, or interfere with the transcription of those genes. Gene editing may be used to engineer immune cells to become more tolerant of particular allergens. This review goes beyond traditional disease therapies by highlighting the latest breakthroughs in this revolutionary field. The applications exemplified in this review reveal how CRISPR can be used to identify the function of allergen proteins and engineer allergen-free plants to develop hypoallergenic foods. But some allergens play vital roles in physiological processes, such as ameliorating biotic and abiotic stress in plants and disease in animals. Just targeting their genes with CRISPR to abolish expression is not always feasible. The benefits and limitations of CRISPR-Cas9-based GE technology are compared with current treatment options.

  • Open Access

    Insights from Stem Cell and CRISPR-Based Therapies for Diabetes Mellitus: A Systematic Review

    by Ahmad M. Khalil

    Diabetes mellitus (DM) is a metabolic disorder resulting from aberrations in insulin secretion or action. Diabetes mellitus still presents as a global health challenge. Conventional diabetes treatment may result in unwanted side effects and/or poor compliance. More personalized and curative approaches to the treatment of DM are required. The review explores recent developments in the fields of genetic and molecular underpinnings of DM, focusing on the revolutionary potential of cell- and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-based genome editing (GE) technologies. An extensive literature survey was carried out using four common databases, the ‘Web of Science’, PubMed, ScienceDirect, and Scholar Google. CRISPR therapy targets crucial genes involved in diabetes pathogenesis. Early data indicate potential improvements in glycemic control among DM patients who have undergone CRISPR-driven modifications related to insulin production. Despite some technical, safety, and ethical limitations, the CRISPR/Cas9-mediated DM treatment is promising due to its sensitivity and specificity. The CRISPR-based DM treatment strategy is a novel, well-studied, sustainable, and more efficient alternative to traditional DM therapies.


  • Open Access

    The Association Between Leptin (-2548 G˃A, rs7799039)/Leptin Receptor (223 A˃G, rs1137101) Polymorphisms and Prostate Cancer

    by Ahmad Khalil, Alaa Helo, Lulu Hussein, Mohammad Kazali

    Background: The pathophysiology of Prostate Cancer (PCa) involves a complex interplay of environmental and genetic factors. PCa diagnosis faces challenges of false-positive outcomes, emphasizing the necessity for revising the available screening methods for PCa. Single-nucleotide polymorphisms (SNPs) have been linked with PCa and constitute a key risk factor in prostate carcinogenesis. Objective: This research aimed at examining the association between susceptibility to PCa and polymorphisms of the Leptin (LEP) gene -2548 G˃A (rs7799039) and LEP receptor (LEPR) gene 223 A˃G (rs1137101). Methods: A total of 66 patients and 34 controls of a Jordanian population were recruited. DNA was isolated from blood leucocytes. Polymorphism analyses were performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) approaches. Results: The mutant allele (A) and genotype (AA) frequencies of the LEP SNP (-2548 G˃A, rs7799039) were significantly higher in the PCa patients (59.1% and 37.9%, respectively) compared to those in the control group (45.6% and 20.6%, respectively) (P = 0.039; OR = 1.88, 95%CI = 1.02 - 2.89 and P = 0.043; OR = 2.86, 95%CI = 1.77 - 5.92, respectively). This indicates that this SNP was associated with an overall increased risk of PCa. In contrast, the LEPR 223 A˃G was not. Further stratification of the PCa group showed that the incidence of both SNPs was correlated with high serum PSA levels and metastasis risk. The results with age and Gleason biopsy score were not conclusive because the trend observed did not reach significance. Conclusions: The findings support our hypothesis regarding the association of the polymorphism in the LEP gene in prostate carcinogenesis (the A and AA frequencies, compared with the control, were associated with a 1.3-fold and a 1.8-fold increased risk for PCa, respectively. However, there was no association between the LEPR (rs1137101) gene variant and PCa risk.

  • Open Access

    Implications of cytokine genes polymorphisms in Jordanian patients with obsessive compulsive disorder

    by Ahmad M. Khalil, Manal W. Khrais, Khaled M. Al-Qaoud, Mohamad Y. Al Ta’aNy

    Background: Obsessive–compulsive disorder (OCD) is a common and often highly debilitating chronic neuropsychiatric condition. There is substantial evidence that immune system and genetic changes are involved in OCD pathogenesis. Only a few studies have been encountered in the literature in this field. We aimed at providing experimental evidence for single nucleotide polymorphisms (SNPs) in candidate cytokine genes for the etiology of OCD. Methods: A total of 52 OCD patients and 54 healthy controls were randomly recruited from the Jordanian population. Age ranged between 16 and 55 years (35.5 ± 13.72 and 33.5 ± 10.48 years) for patients and controls, respectively. Five polymorphic positions in four interleukin genes (IL-1β; rs16944 and rs1143634, IL-6; rs1800795, IL-10; rs1800896 and rs1800795) were genotyped using polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) method. The tumor necrosis factor-α (TNF-α) SNP (rs1800629) DNA was sequenced by the Sanger method. The obtained data were analyzed using the GraphPad Prism method. Results: There were no statistically significant differences between the alleles and genotypes in opposite groups. However, there was a positive association between the incidence of the studied SNP cytokine genes in OCD patients and non-OCD individuals. The alleles of two SNPs (IL-1β + 3954 C > T and TNF-α-308 G > A) were more predominant and more positively correlated with a higher risk in OCD women. In contrast, the link between the gender and the occurrence of the mutant alleles of the other four SNPs IL-1β (− 511 C > T); IL-6 (− 174 G > C); IL-10 (− 1082 A > G); and IL-10 (− 819 C > T was more robust in the males OCD patients than the corresponding females. Conclusion: The observed differences between the alleles in different groups may be due to an association in the tested samples rather than a true association. But, the possibility of a critical effect still exists. One might want to explore this further by repeating the study with a larger sample size.

  • Open Access

    Traditional Strategies and Cutting-Edge Technologies Used for Animal Breeding: A Comprehensive Review

    by Ahmad M. Khalil

    Food security continues to remain a critical challenge confronting humanity. Worldwide, the demand for food products is extensively increasing. Today, the research of generating transgenic organisms is one of the fastest-developing biotechnology fields, as it promises sustainability of agriculture and aquaculture. Many of the animals observed today, including top-quality agricultural breeds such as Holstein cows and Landrace swine, have undergone significant changes and are entirely distinct from their wild ancestors. The reason behind this is that they went through decades of selective breeding (SB) techniques, particularly crossbreeding and mutation breeding. Genome or gene editing (GE) refers to the process of targeted restructuring of a gene at a specific site through genetic engineering (GEN) technology. It ultimately leads to the construction of ‘custom-made animals’ with better hereditary features and amendments. It effectively imitates the natural methods that form the origin of SB programs. However, farmers’ attempts to provide stable productivity and sustainability using traditional breeding proved difficult, inefficient, and time-consuming. So, there is a pressing need for novel strategies for efficient animal breeding today. Compared to conventional breeding techniques, GE is receiving considerable attention, since it can efficiently adjust the target gene to get a GEN animal with desired traits. Developments in animal breeding methods are ongoing, and as each innovation is made, it potentially offers a range of opportunities. The prospects vary between providing targeted production traits such as yield and nutritional profile, improving disease resistance, and expanding animal welfare. This article gives an overview of GE techniques used in breeding livestock models, birds, and fishes. It concludes that applications of GE to improve the traits are the present and future of innovation in animal production. The limitations and future of the breeding process and the development of GE technology in farm animal breeding are also addressed.


  • Open Access

    Morphological, histopathological, and immunohistochemical changes in tissues of adult male Sprague-Dawley rats orally treated with isotretinoin

    by Ahmad Khalil, Amneh Alrabie, Tareq Al-Omari, Hasan Abo Siam, Doaa Ghorab

    Isotretinoin (ISO) is the most effective drug prescribed by dermatologists for the treatment of acne vulgaris and other clinical skin cases. A significant obstacle to using ISO is concerns regarding its adverse effect profile. Despite the well-established reproductive toxicity in females, information on the effects on human male fertility is scarce, contradictory, and inconclusive. This study aimed to investigate the potential histological and histochemical effects of ISO. Isotretinoin was administered orally for seven successive days to Sprague Dawley male rats in a 5-20 mg/kg/day dose range. Standard histological and immunohistochemical techniques were used to evaluate ISO side effects. High doses of ISO led to infiltration of inflammatory cells in hepatic tissues, atrophy of the kidney glomeruli, and collapse of testicular compartments. Decreased E2F4 production was positively correlated to a reduced rate of spermatogenesis. The findings provide further evidence for ISO's cytotoxic and reprotoxic potencies. These effects are probably partly due to slowing down the expression of an E2F4 transcription factor. The dysregulated gene may play an essential role in spermatogenesis. The diagnostic value of the E2F4 gene needs to be further validated by different proteomics approaches, and its precise role in spermatogenesis needs to be investigated.

  • Assessment of the In Vivo Reprotoxicity of Isotretinoin in Sprague-Dawley Male Rat

    by Ahmad Khalil, Mai Daradkeh, Amneh Alrabie, Hasan Abo Siam

    Background: Isotretinoin (ISO) belongs to a family of drugs called retinoids. It is the most effective drug prescribed by dermatologists for the treatment of the inflammatory disease, acne vulgaris. A significant barrier to the use of ISO has worries regarding its adverse effect profile. Despite the well-recognized reproductive toxicity and teratogenicity in females, there is no warning related to the use by male patients in the medication prospectus. Current data on the effects on human male fertility is contradictory and inconclusive. Objectives: This study was undertaken to investigate the potential effects of ISO oral doses in the Sprague–Dawley male rat germ cells using the sperm morphology assay. Also, the serum levels of the follicle-stimulating hormone (FSH), luteinizing hormone (LH), and testosterone were measured. Methods: The rat groups were given varying ISO doses via gastric gavage for seven consecutive days. The epididymis sperm specimens were microscopically examined for the following reproductive toxicity parameters: sperm concentration, examined viability, motility, and morphology. The serum FSH, LH, and testosterone levels were measured by using the corresponding enzyme-linked immunosorbent assay (ELISA) kit. The data were analyzed statistically by one-way analysis of variance (ANOVA) followed by the Tukey test at P ≤ 0.05 significance level. Results: The results indicated that the drug did not significantly increase the sex hormone levels but notably affected both the sperm quantity and quality. Conclusion: These observations suggest that ISO was reprotoxic, and future therapies should be further reassessed.


  • Open Access

    Advances in Epigenome Engineering: Mastering Technical Approaches for Better Outcomes

    by Ahmad Mohammad Khalil

    Epigenomic analysis involves large-scale data science, which poses significant challenges in converting data into usable knowledge. To achieve precise control over gene activation and suppression, a comprehensive understanding of the molecular components of epigenetic processes is essential. Only recently have advancements in technology allowed for the thorough exploration of the functional effects of complex epigenetic pathways. This progress involves integrating nuclease-free genomeediting (GE) systems with effector domains. Contemporary epigenome editing (EpGE) systems can be customized to enable accurate modification of epigenetic marks without altering the DNA sequence itself. This review describes current techniques for epigenetic manipulation and their applications in human health and food. The rise of CRISPR-based EpGE technologies promises to revolutionize the regulation of chromatin and epigenetic markers, providing new opportunities for therapeutic and agricultural purposes. Nevertheless, this emerging field still faces significant hurdles.


  • Open Access

    In vivo cytogenotoxicity testing of isotretinoin by the micronucleus assay in the blood of male Sprague-Dawley rats Isotretinoin is cytotoxic and genotoxic

    by Ahmad Khalil, Hasan Abo Siam, Mai Daradkeh, Amneh Alrabie

    Isotretinoin (ISO), one of vitamin A-derived retinoids, is comparatively the most widely prescribed drug in acne vulgaris pathogenesis. Despite its excellent therapeutic success, the systemic use of this drug showed undesirable serious side effects such as teratogenesis, oxidative stress, and genotoxicity. The uses of retinoids in cancer therapy are limited due to severe adverse reactions. This has led the scientific community to ask for further studies qualifying ISO features and comparing their efficacy and safety. The purpose of this study was to evaluate the cytogenotoxicity of multiple oral doses (5, 10, 15, and 20 mg/kg, daily for seven consecutive days) of ISO in male Sprague-Dawley rats. The micronucleus assay was used to investigate genotoxicity biomarkers such as the percentage of micronucleated polychromatic erythrocytes (%MNPCEs) and the percentage of aberrant cells (%Abc). Another goal was to test the cytotoxicity of the drug by measuring the ratio between PCEs and normochromatic erythrocytes (NCEs) (PCEs/NCEs). In comparison with the control, the three cytogenetic endpoints: %MNPCEs, P/N, and %Abc significantly (P ≤ 0.0017) dose-dependent increase. This suggested genotoxicity and cytotoxicity of the tested ISO doses. Therefore, the therapeutic uses of ISO should be restricted to a very narrow range border. Further studies are needed to shed more light on the safety profile of ISO therapy.


  • Open Access

    Mobile phone radiation might alter gene expression in the oral squamous epithelial cells

    by Ahmad M. Khalil, Khaled M. Al-Qaoud, Israa F. Alemam, Mohammad A. Okour